Advertisement
Product Releases
Advertisement

Fully Resorbable AIGISRx R Antibacterial Envelope

Tue, 07/09/2013 - 10:52am
TYRX

TYRX announces its Fully Resorbable AIGISRx R Antibacterial Envelope for use with pacemakers and implantable cardioverter defibrillators (ICDs) has received FDA clearance. IGISRx R is a fully bioresorbable, antibacterial mesh envelope, intended to hold CIEDs securely in place and provide a stable environment when implanted in the body. AIGISRx R contains antimicrobial agents which are released locally into the tissue, to help reduce surgical site infection associated with CIED implantation. Multiple studies have shown that in patients at high-risk for device infection, CIED implantation with the AIGISRx Antibacterial Envelope significantly reduced device infections by 70% - 100%.

 For more information, visit www.TYRX.com

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading